CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Real-World Prescription Patterns and Barriers Related to the Use of Sodium-Glucose Cotransporter 2 Inhibitors among Korean Patients with Type 2 Diabetes Mellitus and Cardiovascular Disease
Jong Ha Baek, Ye Seul Yang, Seung-Hyun Ko, Kyung Do Han, Jae Hyeon Kim, Min Kyong Moon, Jong Suk Park, Byung-Wan Lee, Tae Jung Oh, Suk Chon, Jong Han Choi, Kyu Yeon Hur, ,
Diabetes Metab J. 2022;46(5):701-712.   Published online June 3, 2022
DOI: https://doi.org/10.4093/dmj.2022.0002

Excel Download

Real-World Prescription Patterns and Barriers Related to the Use of Sodium-Glucose Cotransporter 2 Inhibitors among Korean Patients with Type 2 Diabetes Mellitus and Cardiovascular Disease
Jong Ha Baek, Ye Seul Yang, Seung-Hyun Ko, Kyung Do Han, Jae Hyeon Kim, Min Kyong Moon, Jong Suk Park, Byung-Wan Lee, Tae Jung Oh, Suk Chon, Jong Han Choi, Kyu Yeon Hur, ,
Diabetes & Metabolism Journal. 2022;46(5):701-712   Crossref logo
Link1 Link2 Link3
160-LB: Effect of Sodium-Glucose Cotransporter 2 Inhibitors on Hemodynamic and Metabolic Cardiovascular Markers in Patients with Type 2 Diabetes Mellitus
NATTAPOL SATHAVARODOM
Diabetes. 2019;68(Supplement_1):   Crossref logo
Link1 Link2
Efficacy and Safety of Sodium-Glucose Cotransporter-2 Inhibitors in Korean Patients with Type 2 Diabetes Mellitus in Real-World Clinical Practice
A Ram Hong, Bo Kyung Koo, Sang Wan Kim, Ka Hee Yi, Min Kyong Moon
Diabetes & Metabolism Journal. 2019;43(5):590   Crossref logo
Link1 Link2 Link3
Prescription Patterns of Sodium-Glucose Cotransporter 2 Inhibitors and Cardiovascular Outcomes in Patients with Diabetes Mellitus and Heart Failure
Felix Hofer, Niema Kazem, Bernhard Richter, Patrick Sulzgruber, Ronny Schweitzer, Ulrike Pailer, Andreas Hammer, Lorenz Koller, Christian Hengstenberg, Alexander Niessner
Cardiovascular Drugs and Therapy. 2021;36(3):497-504   Crossref logo
Link1 Link2 Link3
Real-World Treatment Patterns of Glucose-Lowering Agents Among Patients with Type 2 Diabetes Mellitus and Cardiovascular Disease or At Risk for Cardiovascular Disease: An Observational, Cross-Sectional, Retrospective Study
Radhika Nair, Reema Mody, Maria Yu, Stuart Cowburn, Manige Konig, Todd Prewitt
Diabetes Therapy. 2022;   Crossref logo
Link1 Link2 Link3
Sodium-Glucose Cotransporter-2 Inhibitors Ameliorate Liver Enzyme Abnormalities in Korean Patients With Type 2 Diabetes Mellitus and Nonalcoholic Fatty Liver Disease
Won Euh, Soo Lim, Jin-Wook Kim
Frontiers in Endocrinology. 2021;12:   Crossref logo
Link1
Demographic and clinical characteristics of patients with type 1 diabetes mellitus initiating sodium-glucose cotransporter 2 inhibitors in Japan: A real-world administrative database analysis
Norio Abiru, Shingo Shoji, Yoshinori Kosakai, Robert Snijder, Keiko Asakawa, Mitsuhiro Rokuda
Diabetes Research and Clinical Practice. 2022;190:109973   Crossref logo
Link1 Link2
Cardiovascular Safety of Sodium Glucose Cotransporter 2 Inhibitors as Add-on to Metformin Monotherapy in Patients with Type 2 Diabetes Mellitus
Ja Young Jeon, Kyoung Hwa Ha, Dae Jung Kim
Diabetes & Metabolism Journal. 2021;45(4):505-514   Crossref logo
Link1 Link2 Link3
The association of amputations and peripheral artery disease in patients with type 2 diabetes mellitus receiving sodium-glucose cotransporter type-2 inhibitors: real-world study
Sanjoy K Paul, Deepak L Bhatt, Olga Montvida
European Heart Journal. 2020;42(18):1728-1738   Crossref logo
Link1 Link2
Sodium-glucose Cotransporter 2 Inhibitors and Anemia Among Diabetic Patients in Real Clinical Practice: a Retrospective Observational Study.
. 2021;   Crossref logo
Link1 Link2